After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Ionis Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $50.65 and fluctuated between $51.40 as its day high and $50.07 as its day low. The current market capitalization of Ionis Pharmaceuticals Inc is $7.27B. A total of 1.22 million shares were traded on the day, compared to an average of 1.13M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, IONS has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 2,000 shares. Over the last 12 months, there were 39 BUYs and 25 SELLs from insiders. Insiders purchased 167,122 shares during that period but sold 104,798.
In the most recent transaction, Monia Brett P sold 32,059 shares of IONS for 50.42 per share on Jan 17. After the transaction, the Chief Executive Officer now owns 154,136 company shares. In a previous transaction on Jan 17, HOUGEN ELIZABETH L sold 8,683 shares at 50.42 per share. IONS shares that EVP, Finance & CFO owns now total 90,890.
Among the insiders who sold shares, O’NEIL PATRICK R. disposed of 7,744 shares on Jan 17 at a per-share price of $50.42. This resulted in the EVP CLO & General Counsel holding 53,252 shares of IONS after the transaction. In another insider transaction, Geary Richard S sold 7,338 shares at $50.42 per share on Jan 17. Company shares held by the EVP, Chief Development Officer now total 85,475.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for IONS in the last 3 months, the mean price target is $55.44 with high estimates of $85.00 and low estimates of $28.00. In terms of 52-week highs and lows, IONS has a high of $54.44 and a low of $32.69.
As of this writing, IONS has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$1.08. The company reported an EPS of -$0.6 in the last quarter, which was 33.30% higher than expectations of -$0.9.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IONS’s latest balance sheet shows that the firm has $2.11B in Cash & Short Term Investments as of fiscal 2021. There were $1.25B in debt and $240.55M in liabilities at the time. Its Book Value Per Share was $2.20, while its Total Shareholder’s Equity was $771.74M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IONS is Buy with a score of 4.00.
